Andrew Kuykendall, MD, discusses the background, methods, and design of a phase 2 study which evaluated fedratinib.

Thomas Smillie was travelling at 40mph when he failed to slow down at a crossroads on the A697, near Alnwick, and struck ...

The data show that up to 80% of people who are diagnosed with pancreatic cancer have either recently developed Type 2 diabetes or have prediabetes.